(PharmaNewsWire.Com, December 22, 2017 ) The Middle East and Africa Viral Inactivation Market was worth USD 21 million in 2016 and estimated to be growing at a CAGR of 12.8%, to reach USD 38 million by 2021. Viral Inactivation is the method by which virus cells are killed or made inactive. It is mainly done to prevent contamination of products by viruses and hence increase the safety. The viruses present in the final product are thus inactive. These methods are used a lot in food and blood plasma industries to protect the products from viruses.
Some of the methods which are used in virus inactivation are UV irradiation, pasteurization, lowering of pH, dry heating and solvent/detergent usage among others. Viral Inactivation by solvents and detergents is the most used method in the blood plasma industry. It is useful only if viruses are encapsulated in lipid molecules. The detergents/solvents disturb the lipid layers and destroy the viruses as they cannot live without lipid molecules. pH lowering is effective only if the molecules in the final product are more resistant than viruses. Similarly, Pasteurization is useful only if viruses to be killed are less resistant to heat than products to be saved. UV radiations eliminate the viruses by nucleic acid dimerization, thereby affecting their life cycle and reproduction processes.
The driving forces of Middle East and Africa Viral Inactivation market are increasing incidence of chronic diseases, growing support of government in biotechnology and pharmaceuticals industries, increasing attention of research and development sectors in life sciences, rising assistance of government to biotechnology and pharmaceuticals sectors and launch of new drugs among others. However the market is restrained by factors like presence of strong consolidation and less number of skilled workers.
The Middle East and Africa Viral Inactivation market is segmented on the basis of method, product, application and end-user. Based on method, the market is segmented into solvent/detergent method, pasteurization, UV radiation, microwave heating and high-energy light. The largest market share is held by solvent/detergent method since it requires less investment, easy to use and it achieves high degree of inactivation of viruses. Based on product the market is divided into services, kits and reagents, accessories and viral inactivation systems. With respect to application, the market is fragmented into vaccines and therapeutics, stem cell products, cell culture, gene therapy and blood & blood products. Vaccines and therapeutics has the largest share in this segment. Based on end-users, the market is segmented into academic institutions, research organisations, pharmaceutical companies and others.
The market is segmented based on geography broadly into Middle East and Africa. The market in this region is still in its nascent stages. Factors such as rising incidence of chronic diseases, increasing support of government organisations for pharmaceutical and biotechnology industries and introduction of new drugs into the market is expected to drive the growth in this region.
Some of the major players in the market include Clean Cells, Charles River Laboratories International Inc, Danaher Corporation, Merck KGaA, Parker Hannifin, Red Source Technologies, Sartorius AG, SGS S.A, Texcell Inc, Viral Inactivated Plasma Systems SA, and WuXi Pharma Tech Inc.
2)Product Kits and Reagents Services Accesories Viral Inactivation Systems Y-o-Y Growth Analysis, By Product Market Attractiveness Analysis, By Product Market Share Analysis, By Product
3)Application Vaccines and Therapeutics Stem Cell Products Cell Culture Gene Therapy Blood & Blood Products Y-o-Y Growth Analysis, By Application Market Attractiveness Analysis, By Application Market Share Analysis, By Application
4)End User Pharmaceutical and Biotechnology Companies Contract Research Organizations Academic Research Institutes Other End Users Y-o-Y Growth Analysis, By End User Market Attractiveness Analysis, By End User Market Share Analysis, By End User
About us : Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research.
Contact us: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/ View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
